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Abstract
In conducting studies on an exposure of interest, a systematic roadmap should
be applied for translating causal questions into statistical analyses and interpret-
ing the results. In this paper we describe an application of one such roadmap
applied to estimating the joint effect of both time to availability of a nurse-based
triage system (low risk express care (LREC)) and individual enrollment in the
program among HIV patients in East Africa. Our study population is comprised
of 16;513 subjects found eligible for this task-shifting program within 15 clinics
in Kenya between 2006 and 2009, with each clinic starting the LREC program be-
tween 2007 and 2008. After discretizing followup into 90-day time intervals, we
targeted the population mean counterfactual outcome (i.e. counterfactual prob-
ability of either dying or being lost to follow up) at up to 450 days after initial
LREC eligibility under three fixed treatment interventions. These were (i) under
no program availability during the entire follow-up, (ii) under immediate program
availability at initial eligibility, but non-enrollment during the entire follow-up,
and (iii) under immediate program availability and enrollment at initial eligibility.
We further estimated the controlled direct effect of immediate program availability
compared to no program availability, under a hypothetical intervention to prevent
individual
enrollment in the program. Targeted minimum loss-based estimation was used
to estimate the mean outcome, while Super Learning was implemented to esti-
mate the required nuisance parameters. Analyses were conducted with the ltmle
R package; analysis code is available at an online repository as an R package. Re-
sults showed that at 450 days, the probability of in-care survival for subjects with
immediate availability and enrollment was 0:93 (95% CI: 0.91, 0.95) and 0:87
(95% CI: 0.86, 0.87) for subjects with immediate availability never enrolling. For
subjects without LREC availability, it was 0:91 (95% CI: 0.90, 0.92). Immediate
program availability without individual
enrollment, compared to no program availability, was estimated to slightly albeit
significantly decrease survival by 4% (95% CI 0.03,0.06, p< 0:01). Immediately
availability and enrollment resulted in a 7% higher in-care survival compared to
immediate availability with non-enrollment after 450 days (95% CI -0.08,-0.05,
p< 0:01). The results are consistent with a fairly small impact of both availability
and enrollment in the LREC program on in-care survival.
1 Introduction
van der Laan and Rose (2011), Petersen and van der Laan (2014), Pearl (2009) and
others have advocated for the use of a systematic road map for translating causal
questions into statistical analyses and interpreting the results. This road map re-
quires the analyst to learn as much as possible about how the data were generated,
posit a realistic statistical model that encompasses these findings, and assign a cor-
responding estimand that can answer the scientific question of interest. While in
some cases this approach can be straightforward, in practice it generally requires
much consideration when implementing. This is especially true in observational
data, where a common objective is to estimate the joint effect of one or more longi-
tudinal exposures, or series of sequential treatment decisions (for example, Bodnar
(2004), Bryan (2004), Petersen, Tran, Geng, Reynolds, Kambugu, Wood, Bangs-
berg, Yiannoutsos, Deeks, and Martin (2014)). For example, one may be interested
in contrasting immediate enrollment into a particular program (a single treatment
decision) with delayed enrollment (a series of treatment decisions, in which enroll-
ment is sequentially deferred at multiple time points at which it could have been
initiated).
It is well recognized that the cumulative effect of such longitudinal expo-
sures is often subject to time dependent confounding (for example, Robins, Herna´n,
and Brumback (2000a), Bodnar (2004)). For example, the decision to continue to
defer enrollment at post-baseline time points may be affected by covariates that af-
fect the outcome (and are thus confounders), and that are themselves affected by the
prior decision not to enroll. If not properly accounted for, the resulting estimates
may be biased for the parameter of interest.
Similar challenges arise in analyses aiming to estimate the effect of one
longitudinal exposure, while holding a second longitudinal exposure constant. For
example, how would patient outcomes have differed under immediate versus de-
ferred exposure to a clinic level intervention, if individual level enrollment were
prevented? Such a controlled direct effect of two longitudinal exposures can (under
certain assumptions) be used to investigate the mechanisms by which an exposure is
mediated by individual level uptake. In such scenarios, both longitudinal exposures
may be subject to time dependent confounding.
Using the counterfactual framework, Robins (1986) and Robins and Herna´n
(2004) showed that both longitudinal effects and controlled direct effects can be
identified in the presence of such time dependent confounding. A range of es-
timators of such effects (or more precisely, of the statistical estimands to which
the counterfactual effects correspond under the sequential randomization assump-
tion), have been developed, implemented, and applied (e.g. Robins (1987), Robins,
Greenland, and Hu (1999), Robins (2000a), Robins and Herna´n (2004), Herna´n
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and Robins (2006), Pearl (2009)). Prominent examples include, inverse probability
weighted (IPW) (Horvitz and Thompson, 1952, Koul, Susarla, and Ryzin, 1981,
Robins and Rotnitzky, 1992, Satten and Datta, 2001, 2004, Rotnitzky and Robins,
2005, Herna´n and Robins, 2006), parametric g-computation (Robins et al., 1999,
Robins and Herna´n, 2004, Herna´n and Robins, 2006, Taubman, Robins, Mittle-
man, and Herna´n, 2009), and double robust estimating equation-based estimators
(Robins, Rotnitzky, and van der Laan, 2000b, van der Laan and Robins, 2003, Bang
and Robins, 2005, Tsiatis, 2006). More recently, Bang and Robins 2005 also intro-
duced iterated conditional expectation g-computation and double robust estimators,
which van der Laan and Gruber (van der Laan and Gruber, 2011) extended to de-
velop an iterated conditional expectation longitudinal targeted minimum loss-based
estimator (TMLE).
The latter estimator offers a number of advantages, as has been reviewed
elsewhere (van der Laan and Gruber, 2011, van der Laan and Rose, 2011). In
particular, the TMLE does not suffer to the same extent from positivity violations
(Westreich and Cole, 2010) as IPW (Petersen, Porter, Gruber, Wang, and van der
Laan, 2012), and allows for full integration of machine learning while retaining
valid inference (van der Laan and Rose, 2011, Brooks, van der Laan, Singer, and
Go, 2013, Schnitzer, Moodie, van der Laan, Platt, and Klein, 2014, Decker, Hub-
bard, Crespi, Seto, and Wang, 2014). In this paper we describe an application of
this methodology to estimate the joint effect of both time to program availability and
individual enrollment in a task shifting program of routine visits to nurses among
HIV patients in East Africa. We provide a detailed description of this analysis, with
an emphasis on several practical challenges likely to arise in similar applications.
In doing so, we perform a case study of the targeted learning road map in the lon-
gitudinal setting (van der Laan and Rose, 2011, Petersen and van der Laan, 2014,
Petersen, 2014). In particular, we emphasize two primary issues. The first is the
translation of the scientific questions into counterfactual causal parameters, includ-
ing a total effect and controlled direct effect. This is carefully defined as to avoid
known and potential positivity violations. The second is the use of recently devel-
oped estimation methods, including a double robust and semiparametric efficient
targeted minimum loss-based estimator, the integration of Super Learning for nui-
sance parameter estimation, and the imposition of global restraints for conditional
distributions implied by our statistical model. While previous analyses have applied
the longitudinal TMLE method described here (Brooks et al., 2013, Decker et al.,
2014), to the best of our knowledge, this represents the first such application that
integrates advanced machine learning algorithms in an approach known as Super
Learning (van der Laan, Polley, and Hubbard, 2007); we discuss several decisions
and practical challenges that arise as a result, and provide corresponding R code.
The paper is organized as follows. In the second section we provide brief
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background on the scientific question of interest as well as review the targeted learn-
ing road map. In the third section, we present the data as measured and formalized
into a statistical framework. The fourth section posits the causal model for the
data, while the fifth section addresses the target parameter, positivity violations,
and identifiability. The sixth section focuses on estimating both the target and nui-
sance parameters. Section seven presents the results of our approach, while section
eight closes with a discussion and areas of future research.
2 Background
The majority of individuals with HIV live in settings, such as East Africa, where no-
ticeable resource and infrastructure constraints place a limitation on the care these
patients can receive (Stringer, Zulu, Levy, and Stringer, 2006, World Health Organi-
zation, 2013a). Antiretroviral therapy (ART) medication has been shown to reduce
both viral loads and mortality in these patients (Gulick, Mellors, Havlir, Eron, Gon-
zalez, McMahon, Richman, Valentine, Jonas, Meibohm, Emini, and Chodakewitz,
1997, Palella, Delaney, Moorman, Loveless, Jack, Satten, Aschman, and Holmberg,
1998, Zwahlen, Harris, May, Hogg, Costagliola, de Wolf, Gill, Fa¨tkenheuer, Lew-
den, Saag, Staszewski, d’Arminio Monforte, Casabona, Lampe, Justice, von Wyl,
and Egger, 2009, Dieffenbach and Fauci, 2011, Danel, Moh, Gabillard, Badje, Le
Carrou, Kouame, Ntakpe, Me´nan, Eholie, and Anglaret, 2015, Lundgren, Babiker,
Gordin, Emery, Fa¨tkenheuer, Molina, Wood, and Neaton, 2015), as well as re-
duce rates of transmission to persons uninfected (Quinn, Wawer, Sewankambo,
Serwadda, Li, Wabwire-Mangen, Meehan, Lutalo, and Gray, 2000, Attia, Egger,
Mu¨ller, Zwahlen, and Low, 2009, Das, Chu, Santos, Scheer, Vittinghoff, McFar-
land, and Colfax, 2010, Cohen, Chen, McCauley, Gamble, Hosseinipour, Kumarasamy,
Hakim, Kumwenda, Grinsztejn, Pilotto, Godbole, Sanjay, Chariyalertsak, Santos,
Mayer, Hoffman, Eshleman, Piwowar-Manning, Wang, Makhema, Mills, de Bruyn,
Sanne, Eron, Gallant, Havlir, Swindells, Ribaudo, Elharrar, Burns, Taha, Nielsen-
Saines, Celentano, Essex, and Fleming, 2011). However, the shortage of resources
and health care professionals limit the number of patients who can be placed on
ART (Van Damme, Kober, and Laga, 2006, Koole and Colebunders, 2010, World
Health Organization, 2013b, UNAIDS, 2013).
Due to these limitations, various approaches have been undertaken in an
effort to ensure that the maximal number of patients who need care can receive
it. One such approach shifts care provision tasks for patients considered to be at
low risk from physicians and clinical officers to other care professionals, such as
nurses. Consequently, the workload for the physicians and clinical officers is re-
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duced, thereby theoretically increasing the attention that higher risk patients can
receive for HIV or other conditions (World Health Organization, 2013a).
One such program was implemented between 2007 and 2009 among clin-
ics around eastern Africa. These clinics were followed as part of the Academic
Model Providing Access to Healthcare (AMPATH) program, and contributing data
to the International epidemiologic Databases to Evaluate AIDS, East Africa region
(IeDEA-EA). The purpose of this Low Risk Express Care (LREC) program is to
shift care tasks for patients considered to be at low risk from physician-centered
care models to those utilizing non-physician health workers trained in simplified
and standardized approaches to care. Patients were considered to be at low risk if
they met the following set of criteria.
1. They were older than 18 years of age.
2. They were stable on ART for at least 6-months.
3. They had no AIDS-defining or AIDS-associated events within the past 180-
days.
4. During past 6 months, they reported no missed pills when asked about the 7
days prior to each visit.
5. They were not pregnant within the past 30 days.
6. Their most recent CD4 count> 200 cells/µL within 274 days prior to the
current visit.
Once eligible, at each clinical visit, the clinician decided whether or not to
enroll the patient into the LREC program. Patients enrolled had part of their care,
such as identifying and managing ART side effects and opportunistic infections,
shifted to nurses. Table 1 shows the differences between the standard of care and
the LREC model.
Table 1: Proportion of visits responsibility assigned between the (a) standard and
(b) LREC models of care provision. (P = Physician, CO = Clinical Officer)
Clinical monitoring Standard model LREC model
P / CO Nurse P / CO Nurse
Request CD4 / VL counts All None All None
Monitor / support ART adherence All All 1/3 All
Determine functional status All None 1/3 2/3
Identify / manage ART side effects All None 1/3 2/3
Identify / manage opportunistic infections All None 1/3 2/3
In implementing this task-shifting program, a primary question of interest
among health care providers is whether clinic level exposure to and individual level
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enrollment in the program results in either better or worse clinical outcomes. For
example, it could be that enrollment in the program increases loss to follow up
and mortality because care is received from individuals that have a lower level of
qualification/certification. Alternatively, enrollment in the program might decrease
in mortality and loss to follow-up due to more attentive and personal care given to
enrolled patients. It could also be that an equivalent level of care is provided and
thus, no impact is observed. Furthermore, receiving care at a clinic that has already
implemented the LREC program might itself have a direct beneficial or detrimental
effect on patient outcomes, in addition to an indirect effect mediated by patient
enrollment in the program. Such an effect could result, for example, from changes
in clinic practices made possible by shifts in workload.
2.1 Causal Inference road map
We follow the targeted learning road map as presented by van der Laan and Rose
(2011) and Petersen and van der Laan (2014). We briefly summarize the road map
for longitudinal static interventions and corresponding notation below, and refer
readers interested in further details to the cited articles.
Any causal scientific question must first be framed as a statistical question
that can be answered with the observed data. For purely statistical questions, this
includes properly defining the data, statistical model, and estimand or statistical pa-
rameter of interest. Here we consider data that consists of n independent and identi-
cally distributed observations of a random (vector) variable O with some underlying
probability distribution P0. The statistical modelM should be chosen to ensure that
it contains the true distribution P0, and thus any model assumptions should be based
only on real knowledge about the process which generated the data. In practice this
generally implies a semiparametric or nonparametric statistical model.
In order to translate causal questions into such a statistical estimation prob-
lem, the road map further requires translating the scientific question into a formal
causal query. Such a query is typically defined as a parameter of the counterfac-
tual distribution of the data, or equivalently, the distribution the data would have
under some ideal hypothetical experiment or intervention. Here we consider coun-
terfactual experiments indexed by static interventions to set a vector A¯ of treatment
or exposure variables equal to a set value a¯, and denote the resulting counterfac-
tual distribution of the observed data P0a¯ . The statistical model M can then be
augmented with possible additional non-testable causal assumptions about the data
generating process. These causal assumptions are representable using structural
causal diagrams or structural equation models (Pearl, 2009). The resulting causal
modelMF is a model on the counterfactual distribution P0a¯ under each a¯ of interest.
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Finally, one must also determine what additional causal assumptions (if any)
are needed in order to obtain identifiability of the target causal parameter from the
distribution of the observed data. In other words, what additional assumptions on
the data generating process will allow the researcher to express the target causal
parameter ΨF (P0a¯ ) as a statistical estimand Ψ(P0) that is a function of the observed
data alone? In this paper, we focus on the estimand provided by Bang and Robins
(2005) through the longitudinal g-formula, which identified the causal effects of
longitudinal interventions under the sequential randomization assumption.
Once identifiability has been established, the statistical model M and tar-
get parameter of the observed data distribution Ψ(Pa0 ) are used to select a corre-
sponding estimator Ψˆ which is a function of the empirical distribution Pn. This
process may additionally require nuisance parameter estimation. Here, we describe
implementation of a double robust efficient targeted maximum likelihood estima-
tor (van der Laan and Gruber, 2011), based on an iterative conditional expectation
representation of the longitudinal g-formula proposed by Bang and Robins (2005).
The resulting Ψˆ is used in calculating the parameter estimate Ψˆ(Pn) = ψˆn. Corre-
sponding standard errors for the estimates are calculated for inference and results
are then interpreted. In the following sections we illustrate each of these steps in
greater detail using the LREC analysis as a case study.
3 Data
Our study population is comprised of subjects found eligible for the LREC program
within each of 15 clinics in Kenya between 2006 and 2009, with each clinic starting
the LREC program between 2007 and 2008. Table 2 shows the characteristics of
the 15 clinics.
In an effort to ensure that other unmeasured (or unmeasurable) aspects of
care remained roughly constant, the first point of patient eligibility was truncated
at 1-year prior to LREC program initiation at each clinic. Our target population
is therefore comprised of patients found eligible for LREC within 1-year before
the clinic’s start date up to the administrative censoring date (5 March 2009). Our
baseline timepoint (t=0) was defined to be the first date at which a patient was
eligible for the program within this window. Figure 1 shows the distribution of the
time from baseline to start of the LREC program, with negative values representing
patient eligibility post program initiation. A small number of subjects had more
than one year of follow up from baseline to LREC program initiation as a result
of transferring to a new clinic with a later LREC start date. As patients generally
visited clinics every three months, we discretized follow-up into time intervals of
90 days.
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Table 2: LREC program clinic characteristics (n=15).
Area No.(%)
Urban 6 (40.0)
Rural 9 (60.0)
Clinic Type No.(%)
Referral hospital 3 (20.0)
(Sub) district hospital 7 (46.7)
Rural health center 5 (33.3)
Patients No.(%)
≤ 500 4 (26.7)
501−1000 3 (20.0)
1001−1500 4 (26.7)
> 1500 4 (26.7)
0
1000
2000
3000
−500 0 500 1000
Days
Co
un
t
Figure 1: Histogram of time from eligibility to LREC program initiation.
Patients were followed from the baseline time point defined above until one
of four possible end points:
1. Death
2. Loss to follow-up (LTFU), defined here to be 6.5 months with no clinical
visits
3. Database closure, occurring on 5 March 2009
4. Transfer to a clinic with no LREC program
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For the present study, we were interested in the effect of LREC exposure and
enrollment on the probability of both death and remaining in clinical care. Patients
who do not return for continuing HIV care are subject to higher risk of complica-
tions and health decline (Kissinger, Cohen, Brandon, Rice, Morse, and Clark, 1995,
Samet, Freedberg, Savetsky, Sullivan, Padmanabhan, and Stein, 2003, Giordano,
Visnegarwala, White, Troisi, Frankowski, Hartman, and Grimes, 2005, Giordano,
Gifford, White, Almazor, Rabeneck, Hartman, Backus, Mole, and Morgan, 2007,
Horstmann, Brown, Islam, Buck, and Agins, 2010), placing them at unnecessarily
higher mortality rates. We therefore define our outcome of interest as a composite
of either the occurrence of death or LTFU. Patients were followed until this “fail-
ure” or until censoring due to either end of study or transfer. We aimed to evaluate
the impact of (a) implementation of the LREC program at the clinic, and (b) enroll-
ment into the LREC program after implementation on both retention “in-care” and
survival.
3.1 Observed data
For notational convenience, we defined variables after the occurrence of any of
these end points as equal to their last observed value. Following discretization of
the data, we have a longitudinal data set with time-varying covariates, where the
time points t correspond to 90-day intervals (e.g. 0, 90, 180, ... days). Let W be
the observed baseline time-independent covariates observed at the date the patient
was first eligible for LREC (age at eligibility, CD4 count at start of ART, gender,
indicator that ART regimen is PI-based at eligibility, treated for tuberculosis at start
of ART, indicator at urban clinic at eligibility, and WHO immunologic stage at both
the start of ART and maximum stage prior to start). Let the time-varying variables
from the observed data for each time point t be:
O(t) = (L1(t),Y (t),A1(t),A2(t),C1(t),C2(t)) : t = 0,1, . . . ,K, (1)
where
• L1(t) consists of the most recent measures of time-varying covariate values at
the start of interval t, inclusive of covariates measured at the clinic level (i.e.
calendar date, most recent, nadir, and zenith CD4 count, days since enrolling
into the AMPATH program, an indicator of remaining on ART, pregnancy
status, indicator in WHO stage III or IV, indicator of being treated for tuber-
culosis, clinic type (rural or urban), and an indicator of having at least one
clinic visit in the previous interval).
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• Y (t) is an indicator that the patient is either (a) no longer in care (not seen in
the clinic for 6.5-months) or (b) has died by the end of interval t. It jumps to
and remains at 1 if either event occurs.
• A1(t) is an indicator of the LREC program availability by the end of interval
t. It jumps to and remains at 1 once the program has started.
• A2(t) is an indicator of enrollment into the LREC program by the end of the
interval. It jumps to and remains at 1 at time of enrollment and remains at 0
if A1(t) = 0.
• C1(t) is an indicator that the patient transfers by the end of interval t to a
clinic other than one of the 15 clinics that initiate the LREC program. It also
jumps to and remains at 1 once the patient transfers.
• C2(t) is an indicator of data base closure by the end of interval t. It jumps
to and remains at 1 at the end of the study. Note that although database
closure occurs at a fixed calender date, censoring time due to database closure
remains a random variable due to variability in time of eligibility for LREC.
To simplify notation, we refer to the covariate and outcome nodes collec-
tively as L(t) = (L1(t),Y (t)). Furthermore, we refer to the treatment and censoring
processes together as A(t) = (A1(t),A2(t),C1(t),C2(t)). By additionally defining
L(0) to include our baseline variables W such that L(0) = (W,L1(0),Y (0)), our
observable data for each subject i can be expressed as
Oi = (Li(0),Ai(0),Li(1),Ai(1), . . . ,Li(K+1)) (2)
where K + 1 is our final time point of interest, here equal to 4 (or equiv-
alently 450 days after LREC eligibility). We assume the observed data over all
subjects consists of n copies of Oi
iid∼ P0 ∈M , where P0 is the true underlying dis-
tribution (residing in a statistical modelM ) from which the data are drawn.
4 Causal model
A causal model allows us to represent additional knowledge and assumptions as-
sociated with our scientific question that cannot be represented statistically. We
present our causal model MF by making use of structural equation models to
formally present how we assume each variable to be generated. We use a causal
model that treats the 15 clinics as fixed, rather than sampled, and which describes
an experiment in which individual subjects become eligible for LREC at random
times. Specifically, we define the following non-parametric structural equation
model (NPSEM) (Pearl, 2009) to represent our knowledge about the causal pro-
cess that generated the observed data.
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L1(t) = fL1(t)(L¯(t
−), A¯(t−),UL1(t))
Y (t) = fY (t)(L¯(t
−), A¯(t−),UY (t))
for t = 0,1, . . . ,K,K+1
A1(t) = fA1(t)(L¯(t), A¯(t
−),UA1(t))
A2(t) = fA2(t)(L¯(t), A¯(t
−), A¯1(t),UA2(t))
C1(t) = fC1(t)(L¯(t),Y (t
−), A¯(t−),A1(t),A2(t),UC1(t))
C2(t) = fC2(t)(L(0),Y (t
−),C¯(t−),C1(t),UC2(t))
for t = 0,1, . . . ,K
(3)
where U ≡ (UL1(t),UY (t),UA1(t),UA2(t),UC1(t),UC2(t)) are unmeasured ex-
ogenous variables from some underlying probability distribution PU and L(−1) =
A(−1) =∅. For notational convenience, we define t− = t−1.
This causal model specifies how we believe each of the variables in our data
are deterministically generated, with randomness coming only from the unmea-
sured exogenous variables U . It tells us, for example, that individual enrollment
immediately following LREC eligibility A2(0) is generated as a deterministic func-
tion fA2(0) of L(0), program availability A1(0), and an error term UA2(0) drawn from
some underlying population. Additionally, while not explicitly stated in Equation
(3), we note that the deterministic function for enrollment fA2(t) sets A2(t) = 0 with
probability 1 if A¯1(t) = 1, i.e. if the program is not yet available.
Note that censoring due to end of study C2(t) is not a function of time
updated covariates L¯(t) beyond baseline covariates L(0). This is because, while
the values of L(0) may vary due to the calender date at which a subject’s baseline
eligibility occurs, once this date is set for a given subject, the censoring process due
to database closure is deterministic.
Our outcome Y (t) is assumed to be a function of treatment and censoring
A(t) only up to the previous time point, t − 1. This restriction is imposed in or-
der to avoid the possibility of reverse causality, i.e. that death/LTFU (Y (t)) that
occurs in an interval t affects availability/enrollment (A(t)) in the same interval.
Consequently, the effects of availability and enrollment within an interval on the
composite outcome are only captured beginning in the following interval.
5 Target parameter
The outcome at t = 0 is independent of any potential treatment assignments A(t).
As the purpose of this study is to analyze the impact of different levels of treatment
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on the outcome, we conditioned on survival past t = 0. Thus, we had that Y (0) = 0
for all subjects included in the study. That is, all subjects in the study survived past
the first 90 days.
Conceptualizing an ideal hypothetical experiment can help in defining the
target counterfactual parameter of interest. In order to evaluate the effect of expo-
sure to and enrollment in the LREC program, we can conceive of an experiment in
which we compare survival over time under alternative interventions to set time to
program availability, time to enrollment following availability, and under an addi-
tional intervention to prevent censoring. As represented above in the causal model,
these counterfactual outcome distributions are defined in terms of an intervention
on the data-generating mechanism for A(t) : t = 0,1, . . . ,K. In other words, we
intervene to set values of program availability, enrollment, and censoring to some
fixed values of interest at all time points.
Recall that our interest is evaluating both the total effect of exposure to the
LREC program, and the direct effect of this exposure not mediated by individual
level enrollment. Let Y¯a¯(t∗) denote the counterfactual outcome process over time
t∗ under an intervention to set both time of program availability (a¯1) and time of
individual enrollment (a¯2). Our target parameter for a given intervention of interest
is EYa¯(t∗) : t∗ = 1, . . . ,4, where EYa¯(t∗) is the cumulative counterfactual probability
of failure by time t∗ under intervention a¯. As we have conditioned on surviving past
t = 0 (the first 90-days of follow-up), our range represents the cumulative probabil-
ity of failure from 180 to 450 days post-eligibility.
When contrasting counterfactual failure probabilities under distinct inter-
ventions, we focused on estimating the absolute risk difference (or average treat-
ment effect). Specifically, we contrasted these counterfactual survival probabili-
ties under the three following interventions: Our first intervention assigns all pa-
tients to have no program availability at all time points (set A1(t) = A2(t) = 0 : t =
1,2, . . . ,K), and forces patients to remain uncensored (set C1(t) =C2(t) = 0 : t =
1,2, . . . ,K). The corresponding 4 counterfactual survival probabilities EYa¯=00(t∗) :
t∗ = 1, . . . ,4 give us an understanding of survival patterns without the LREC pro-
gram.
The second intervention of interest is to assign all patients to have imme-
diate program availability (set A1(t) = 1 : t = 1,2, . . . ,K), but not allow any sub-
jects to enroll into the program (set A2(t) = 0 : t = 1,2, . . . ,K). Patients would
again be forced to remain uncensored and the counterfactual survival probability
at each time point EYa¯=1,0(t∗) : t∗ = 1, . . . ,4 would be calculated. By evaluating
Ψ1,0(P0) = EYa¯=1,0(t∗)−EYa¯=0,0(t∗) : t∗ = 1, ...,4, we target the controlled direct
effect of exposure to the program if enrollment were prevented.
The third intervention is to assign all patients to have both immediate avail-
ability and enrollment (set A1(t) = A2(t) = 1 : t = 1,2, . . . ,K). Again, censoring
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would be prevented and the counterfactual survival probability at each time point
EYa¯=1,1(t∗) : t∗= 1, . . . ,4 would be calculated. EvaluatingΨ1,1(P0)=EYa¯=1,1(t∗)−
EYa¯=1,0(t∗) : t∗ = 1, . . . ,4 allows us to target the total effect of enrollment in a sce-
nario where all subjects experienced immediate availability.
5.1 Identifiability
5.1.1 Sequential randomization
To establish identifiability of our causal parameter, we first make the assumption of
sequential randomization. That is, we assume that
Y¯a¯(t∗)⊥ A(t)|L¯(t−1), A¯(t−1) : t = 0, ..,3. (4)
This is equivalent to assuming that the measured covariates are sufficient to control
for confounding of our treatment effect. In this context, the major concern for
violation of this assumption is that among patients classified as clinically stable,
some patients are healthier or at lower risk of loss than others in ways not captured
by the measured covariates, and these patients are differentially enrolled into the
program.
5.1.2 Positivity
In addition, we assume that a subject had a positive probability of following each
regime of interest (no availability, immediate availability and no enrollment, and
immediate availability and enrollment) at each time point, regardless of their ob-
served past:
P(A(t)= a(t)|L¯(t−1)A¯(t−1)= a¯(t−1))> 0 a.e. for t = 0, ..., t∗−1, a¯∈{00,10,11}.
(5)
Patients losing their eligibility for the LREC program posed a particular threat to
this assumption. Our study population is comprised of patients initially deemed eli-
gible for the LREC program due to their low risk. However, a noticeable proportion
of the study population (32%) lost their eligibility at some point during follow-up.
Once these patients were ineligible, they had a 0 probability of subsequent program
enrollment. To circumvent this potential positivity violation, we considered only
treatment interventions which avoided enrollment at these time points. For exam-
ple, consideration of patients who enroll immediately into the program would not
encounter this issue, as all patients are eligible at the start of follow-up. Consid-
eration of patients never enrolling into the program is also valid, as patients who
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are not eligible do not enroll. We further note that patients who lost their eligibility
after enrollment into the LREC program were still considered to be enrolled. Sim-
ilarly, patients who transferred to a new clinic without availability after receiving
care at a clinic where LREC was available were considered exposed to the LREC
program (in other words, we conducted an intent to treat type analysis of the effect
of both availability and enrollment).
Under the assumptions of positivity and sequential randomization, the g-
formula (Robins, 1986, 1987) identifies the distribution that the observed data would
have had under a counterfactual treatment, even when time-dependent confounders
are present and are affected by prior components of the specified treatment. For our
parameter, the standard g-computation representation for our target parameter is
EYa¯(t∗) = ∑
l¯(t∗)
E(Y (t∗)|L¯(t∗−1) = l¯(t∗−1), A¯(t∗−1) = a¯(t∗−1))·
t∗−1
∏
j=0
P(L( j) = l( j)|L¯( j−1) = l¯( j−1), A¯( j−1) = a¯( j−1)
(6)
where the right hand side is a parameter of the observed data distribution P0.
The g-computation recursive algorithm for estimating the cumulative probability of
failure, introduced by Robins (2000b) and expanded in Bang and Robins (2005),
calls upon the tower rule of conditional expectations for this identity, suggesting
an iterative conditional expectation (ICE) approach to estimating our parameters.
Using their results, our parameter can therefore instead be expressed as
E[E[· · ·E[E[Y a¯(t∗)|L¯a¯(t∗−1)]|L¯a¯(t∗−2)] · · · |L¯a¯(0)]] (7)
where La¯(t) is the variable L(t) from the post intervention distribution resulting
from setting A¯(t−) = a¯(t−) and the expectations are taken with respect to this dis-
tribution. Thus, given L¯a¯(t) is equivalent to conditioning on L¯(t), A¯(t) = a¯(t).
6 Estimation
The ICE approach has a number of advantages to the more simple standard g-
computation procedure. The most noticeable among them is that we are only re-
quired to estimate the iteratively defined conditional expectations as opposed to the
entire conditional densities of the covariate process L(t). We therefore use the ICE
approach here. A small disadvantage is that these set of regressions must be run
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separately for each desired treatment rule, a¯, whereas in using the original formu-
lation one only has to estimate the conditional densities once. We note however
that this is a very small price to pay when compared against the substantial gain
achieved by not having to estimate the entire joint density, especially when dealing
with high dimensional data.
While the ICE approach already provides a considerable advantage towards
our estimation goals, using targeted minimum loss-based estimation (van der Laan
and Gruber, 2011) provides a further gain. This approach, which builds upon the
double robust ICE estimator of Bang and Robins (2005), solves the derived effi-
cient influence function D(P) for our estimand within a substitution based setting.
This removes the bias associated with the untargeted minimization of a global loss
function for the density of the data. It is also known to be double robust, in that
consistent estimation of the target parameter is obtained if either of the treatment
or outcome distributions are estimated consistently. This approach is guaranteed
to respect the parameter constraints implied by our statistical model. An R pack-
age titled ltmle has been developed which implements this estimator (Schwab,
Lendle, Petersen, and van der Laan, 2014, Petersen, Schwab, Gruber, and Blaser,
2013). This package takes longitudinal data supplied in wide format and estimates
our target parameter for each specified treatment rule a¯.
A number of options are available to users of the ltmle R package. For
example, the probabilities of treatment and censoring A(t) at each time point (for
the specified treatment rule a¯) can be separately estimated and subsequently fed into
the estimation procedure, rather then being fit within. This allows the analyst the
option of pooling the observations over all time points and estimating probabilities
within this pooled sample, as opposed to fitting separate models for each time point.
Doing so provides a lower variance in estimates of the treatment mechanisms at the
cost of potentially higher bias.
An additional advantage of pooling over all observations in estimating our
treatment and censoring mechanisms is that we can use additional data that is not
included in modeling the ICEs. That is, data observed beyond the final time point
t∗ can be used to aid in estimating the probabilities of treatment for A(t) : t =
0,1, . . . , t∗−1. This can be advantageous and promotes stability in the estimates by
borrowing information across all time points. Specifically, it helped in the present
study in estimating our censoring from transfer mechanism, due to the extremely
small number of transfers observed. For this study, we choose to pool across obser-
vations to fit the treatment mechanisms though note that the decision between the
two did not significantly affect the parameter estimates.
An additional package option is the ability to pool over all subjects when
estimating the ICEs irregardless of observed treatment, as opposed to stratifying
the data and using only subjects following the treatment rule specified. This choice
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implies an analogous bias-variance trade off. Pooling over subjects regardless of
treatment history potentially allows for more stable estimates of the ICEs due to the
smaller variance. This option is helpful when the number of time points is large and
the number of persons following a particular treatment regime over all time points
is small.
Use of the ltmle R package requires that the data be provided in a wide
format and with a time-ordering of the covariates. In doing so, two options are
available for the L(t) node at each time point t, i.e. L1(t),Y (t) or Y (t),L1(t). In
our causal model in Section 4, the L(t) node is not affected by the specified order.
Therefore, use of either ordering will suffice in our study. We additionally note,
however, that even if the time-ordering did matter and our outcome of interest Y (t∗)
were, say, dependent upon the covariates L1(t∗), there is still no need to condition
on L1(K + 1) for the sake of estimating our target parameter as the efficient influ-
ence function D(P) for our parameter based on the full data O is the same as the
efficient influence function based on reduced data Or = O/L1(K+1). We provide
a short proof for this in the Appendix.
6.1 Super Learning the nuisance parameters
Consistent, asymptotically linear, and efficient estimation of our target parameter
requires that the treatment and censoring A(t) mechanisms as well as ICEs be es-
timated in a consistent manner and at a fast enough rate, i.e. op(1/
√
n). Using
parametric models to do this requires correct specification of the functional form
for the conditional densities. Given that we do not know a priori the form of the
true probability distribution P0 and the extreme unlikeliness that a simple paramet-
ric specification will result in a correctly specified model, use of these models will
most likely result in overly biased estimates which will approach statistical signifi-
cance with probability 1 as sample size increases regardless of whether a treatment
effect exists. In other words, the use of misspecified parametric models elevates the
risk of obtaining significant findings even if no true treatment effect is present.
An alternative approach is to use data-adaptive non-parametric methods
which reside in a much larger statistical model or set of distributions. Examples
include gradient boosting machines (Friedman, 2001, 2002), neural networks (Mc-
Culloch and Pitts, 1943), and k-nearest neighbors (Altman, 1992). In deciding
which method to use, we recommend using the ensemble machine learning ap-
proach Super Learner, which is based on V-fold cross validation and implemented
in the R package titled SuperLearner (Polley and van der Laan, 2014). This algo-
rithm takes a user-supplied loss function (chosen to measure performance) and a li-
brary of algorithms, which can include parametric models as well as non-parametric
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or machine learning algorithms such as those listed above. It uses V-fold cross val-
idation to chose the convex combination of these algorithms that performs best on
independent data (derived from internal data splits). If, as is likely, none of the
algorithms in the library achieves the rate of convergence one would have with a
correctly specified parametric model, the Super Learner will still perform asymp-
totically at least as well as the best algorithm in the library. Otherwise, it achieves an
(almost) parametric rate of convergence. Furthermore, the derived oracle inequal-
ity showing the asymptotic performance also shows that the number of candidate
algorithms considered in the cross-validation procedure can be polynomial in size
proportional to the number of observations (van der Laan and Dudoit, 2003, van der
Vaart, Dudoit, and van der Laan, 2006, van der Laan et al., 2007). Therefore, a large
number of algorithms can be considered, which can grow with the number of ob-
servations, without fear of hampering the Super Learner’s performance.
To use Super Learning, a loss function must be chosen and a user-specified
library provided. We chose the non-negative log loss function for its desired steeper
risk surface, as this function penalizes incorrect probabilities more severely than
the more commonly used squared error loss. A number of default candidates are in-
cluded in the SuperLearner package that were used here. These include the overall
mean, main terms logistic model, step-wise regression with AIC (Hoerl and Ken-
nard, 1970), generalized additive model (Hastie and Tibshirani, 1990), Bayesian
generalized linear model (Gelman, Jakulin, Pittau, and Su, 2008), k-nearest neigh-
bors (Altman, 1992), LASSO (Tibshirani, 1996), ridge regression (Hoerl and Ken-
nard, 1970), neural net (McCulloch and Pitts, 1943), multivariate adaptive poly-
nomial spline (Friedman, 1991), generalized boosted regression model (Friedman,
2001, 2002), and support vector machine (Boser, Guyon, and Vapnik, 1992, Cortes
and Vapnik, 1995). Additionally, most of the algorithms have tuning parameters
which can result in better candidate performance. To ensure that we were achieving
satisfactory performance, we used different tuning parameters as additional can-
didates in the ensemble for the generalized additive models, k-nearest neighbors,
neural nets, and generalized boosted regression models. We additionally used 4
user-specific parametric models as candidates in the library. The Super Learner fits
were constructed using all potential confounders, listed above in Section 3.1 as W
and L1(t) for each time point t.
Of particular concern to the analyst when deciding on which candidates to
include in the Super Learner library is the explicit condition that the candidates
not be too data adaptive. This is because the empirical process conditions for the
asymptotic linearity of our estimator require that we work within a Donsker class of
estimators (van der Laan, Rose, and Gruber, 2009). Indeed, we have seen that algo-
rithms that tend to overfit the empirical data, such as the machine learning algorithm
random forest, will negatively impact our estimators. We therefore excluded these
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algorithms from our library, though note that such algorithms could still be used
in a cross-validated parameter estimation approach such as cross-validated targeted
minimum loss-based estimation (Zheng and van der Laan, 2010).
Regarding the pooling of observations across time for the treatment mech-
anism, one further possible option is to use a Super Learner library that is doubled
by including estimates from both the time stratified and pooled approach. Ensem-
ble weights could then be calculated based on the best performing candidate in
this larger library and subsequently fed into the ltmle package. Consequently, we
continue benefiting from the borrowed information at different time points and si-
multaneously protect ourselves from the asymptotic bias of the previous approach.
We opted not to additionally use the stratified approach, due to the computational
intensity required of the approach.
6.1.1 Initial ICE fits
In using non-parametric estimators for the estimation of the ICEs, we may poten-
tially disregard the global constraints implied by our statistical model. While all the
estimators considered here are expected to work well at time t = t∗ where the out-
come being modelled is binary, their use at t < t∗ where the outcome being modelled
is known to fall within the interval [0,1] can present issues. For example, continu-
ing to treat the outcome being modelled as binary may result in programmatic errors
since many of the algorithms, such as Support Vector Machines or k-nearest neigh-
bors, require that the outcome be supplied in classes or as factors. Alternatively,
modelling the outcome continuously may result in extrapolations with estimates
greater than 1 or less than 0. As our expectation is known to fall within [0,1], this
would result in violations of the constraints of the outcome being modelled.
For each of the algorithms facing this potential issue, we implemented three
approaches aimed at ensuring that estimates remained within the constraints. All
three were used in the Super Learner library, allowing us to objectively compare
the performance of each approach. We define each of the conditional expectations
from Equation (7) to be Q¯0,L(t) such that, for example, Q¯0,L(t∗) ≡ E[Y a¯(t∗)|L¯a¯(t∗−
1)] and Q¯0,L(t∗−1) ≡ E[Q¯0,L(t∗)|L¯a¯(t∗− 2)]. Let each estimator of the conditional
expectation within the Super Learner library at time t be denoted as Q¯ jn,L(t) for
j ∈ 1,2, . . . ,J where J is the total number of candidates in the Super Learner library.
We considered
1. Simply truncating Q¯ jn,L(t) at both 0 and 1.
2. Taking the logit transformation of the outcome being modelled and truncat-
ing at a fixed threshold τ (set here to be 0.0001). We then modelled the
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transformed outcome on a continuous scale and took the inverse logit trans-
formation on the fitted values.
3. Stratifying the observations by whether they were within the (0,1) open in-
terval or within {0,1}, i.e. whether they were continuous within the (0,1)
interval or dichotomous with only values of 0 or 1. The former were fit on
a continuous scale after taking the logit transformation, while the latter were
modelled as a binary outcome.
We emphasize that use of Super Learner for estimation of the treatment
mechanisms and ICEs provides two important primary benefits. Firstly, its use
helps ensure the conditions for the asymptotic linearity of our estimator and the
corresponding statistical inference are met by ensuring the consistent estimation
of both the intervention mechanism and the iteratively defined conditional expec-
tations. This allows us to establish robust confidence intervals for our estimator.
Secondly, we gain efficiency in that we get an asymptotically efficient estimator if
both the treatment mechanisms and ICEs are estimated consistently at fast enough
rate. Thus, as long as at least one of the library candidates for each of the nuisance
parameters achieve this optimal rate, our approach will have the lowest variance
among all regular asymptotically linear estimators. Further, even if we fall short
of this goal, the improved estimation of both nuisance parameters offered by Super
Learner will generally improve finite sample efficiency.
7 Results
Among the 15 clinics implementing the LREC program, a total of 16,513 subjects
(31 % male) were found to be eligible for the program, of which 16,479 survived
past t = 0. As we only modelled survival up to 450 days, we report figures with
follow-up truncated at that point. After discretizing the data, these patients con-
tributed a total of 17,668 person-years of follow-up to the analyses. From these
subjects 1,206 failure events were observed, of which 1,102 were losses to follow-
up and 104 were deaths. All failure events observed at t = 1 were deaths, since our
definition of loss to follow-up required at least 6.5 months to pass before a subject
could be lost to follow-up. A small number of subjects (n=128) were censored due
to transfers to non-LREC clinics, while 3,889 subjects reached the end of study
prior to t = 4 and prior to experiencing a failure event and were administratively
censored. Table 3 shows the characteristics of the patients conditioning on survival
past t = 0.
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Table 3: Characteristics of 16,479 patients at LREC eligibility (conditioning on
survival past t = 0).
Count (%)
Age (years)
<30 2,793 (17%)
30-39 7,017 (43%)
≥40 6,669 (40%)
Sex
Female 11,441 (69%)
Male 5,038 (31%)
CD4 cell count (cells/µL) at ART start
<200 9,754 (59%)
200-349 2,313 (14%)
350-499 543 (3%)
≥500 387 (2%)
Unknown 3,482 (21%)
CD4 cell count (cells/µL) at baseline
<200 0 (0%)
200-349 10,125 (61%)
350-499 4,016 (24%)
≥500 2,334 (14%)
Unknown 4 (0%)
PI-based ARV regimen
No 15,600 (95%)
Yes 879 (5%)
Max WHO stage prior to ARV start
I/II 7,696 (47%)
III/IV 8,373 (51%)
Unknown 410 (2%)
A small proportion of subjects died (42), were lost to follow-up (286), or
were censored (60) before the LREC program became available. Of the 16,050 sub-
jects who were at some point exposed to the program, most (15,294) experienced it
by 1-year from baseline. Almost half of the study population began follow-up after
the LREC program had already initiated, as indicated by the large spike in the cu-
mulative incidence at time 0 (Figure 2). A noticeable spike was also seen at 1-year
after baseline, representing the patients who had their first eligibility truncated at
1-year as stated in Section 3.
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Patients who were not exposed to the LREC program could not enroll. Fur-
thermore, once the LREC program was available, decisions on whether to enroll
subjects rested upon the treating clinicians or clinical officers. Consequently, only
3,832 subjects were enrolled. As expected, subjects who were healthier were more
likely to enroll into the LREC program. For example, univariate analyses showed
that subjects who had higher CD4 counts, were receiving ARV, had a WHO stage I
or II, were seen in clinics less often, and were not being treated for tuberculosis had
higher probabilities of enrolling. Additionally, subjects from (sub) district hospitals
and rural health centers (compared to referral hospitals), with fewer missed clini-
cal visits, not on protease-inhibitor based regimen, and who were not pregnant also
had higher probabilities of enrolling. We note that despite listing non-pregnancy
as a criteria for being at low risk, a small number of subjects (18) enrolled while
pregnant. Figure 2 shows the cumulative incidence of LREC availability and en-
rollment. Cumulative incidence of enrollment by 90 and 360 days after baseline
was 7% (95% CI: 6.3%, 7.1%) and 19% (95% CI: 18.8%, 20.1%), respectively.
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Figure 2: Cumulative incidence of LREC availability and enrollment and 95% con-
fidence interval.
As stated in Section 3, all patients in our study started follow-up eligible for
the LREC program, leading to low or no variance in many of the confounders at
early time points with a skewness towards the healthier values. During follow-up,
however, many subjects who did not enroll subsequently became less healthy re-
sulting in decreased probabilities of subsequent enrollment. These covariates mea-
suring their health and enrollment probabilities therefore represent classical time-
dependent confounding and should be adjusted for appropriately (Robins et al.,
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2000a). Indeed, 3,920 subjects were found to have lost their eligibility prior to en-
rollment and prior to 1-year, precluding interventions to evaluate a range of different
enrollment times, as discussed in Section 5.1.2.
Unadjusted analyses using the Kaplan-meier estimator showed overall high
probabilities of in-care survival among all subjects (Figure 3). Those with immedi-
ate LREC availability who never enrolled had noticeably lower in-care survival than
subjects never experiencing LREC availability. For example, at t = 4 the propor-
tion of subjects still alive and in care was 0.77 for those not enrolling into LREC,
compared to 0.93 for the group of subjects never experiencing LREC availability
and 0.94 for subjects enrolling into LREC immediately. Conversely, those with
immediate enrollment into the program had the highest survival probabilities. Dif-
ferences in survival probabilities between treatment groups increased with time,
with the largest differences seen between subjects with immediate enrollment and
those with LREC availability never enrolling.
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Figure 3: Unadjusted Kaplan-Meier survival curves.
The cross-validated risks (using the non-negative log likelihood loss) for the
treatment and censoring mechanisms are shown in Figure 4 under various models
and algorithms. While observations at all time points were used in the mecha-
nism fits, our interest is only in treatment interventions at t ≤ 3. We therefore
only calculated the risks using those time points. As expected, the Super Learner
fit outperformed all of the candidate estimators in the supplied library, as well as
the cross-validation selector (i.e. discrete Super Learner, which is equivalent to
choosing the single algorithm in the library with the lowest cross validated risk).
Compared to the mean model, which assumes no confounding and does not control
for any confounders, the Super Learner fits for the LREC availability and end of
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study mechanisms showed an immense decrease in cross-validated risk. This gain
was also noticeable when compared to the candidate model that only controls for
time. The Super Learner fit for the enrollment mechanism also outperformed the
mean model, though to a smaller degree. No noticeable gain was seen in the trans-
fer mechanism, presumably due to the extremely low number of transfers observed
(218). We did not present the cross-validated risks for the ICE fits as they are too
numerous to describe in detail, though note that they were similar to fits for the
treatment and censoring mechanisms.
Adjustment for potential confounders using the Super Learner fits resulted
in relatively small updates of the survival curves (Figure 5). Subjects enrolling
immediately into the LREC program at eligibility continued to have the highest
survival probabilities, while those with immediate availability not enrolling had the
lowest. Tables 4 and 5 show the calculated average treatment effects between the
different interventions. Confidence intervals and p-values were calculated based
on influence functions. As implied by the survival curves, immediate enrollment
into the LREC program at eligibility had a beneficial effect relative to never having
LREC available, while having LREC immediately available and never enrolling
was adverse. For example, at t = 4 the probability of survival for subjects with
immediate enrollment was 0.93 (95% CI: 0.91, 0.95) and 0.87 (95% CI: 0.86, 0.87)
for subjects with immediate availability never enrolling. For subjects without LREC
availability, it was 0.91 (95% CI: 0.90, 0.92). Similar to the unadjusted estimates,
the treatment effects increased with time. All estimates after t = 1 showed statistical
significance.
Table 4: Unadjusted time-specific average treatment effects. (a) compares the in-
tervention immediate LREC availability without enrollment to never having LREC
available; (b) compares the intervention immediate LREC availability and enroll-
ment to immediate LREC availability without enrollment.
(a) EYa¯=10(t∗)−EYa¯=00(t∗) (b) EYa¯=11(t∗)−EYa¯=10(t∗)
Time (t∗) Estimate (95% CI) p-value Estimate (95% CI) p-value
1 0.00 (0.00,0.00) 0.93 0.00 (0.00,0.00) 0.56
2 0.03 (0.02,0.03) 0.00 -0.04 (-0.05,-0.03) 0.00
3 0.04 (0.03,0.05) 0.00 -0.05 (-0.07,-0.04) 0.00
4 0.06 (0.05,0.08) 0.00 -0.07 (-0.09,-0.05) 0.00
It is possible that near positivity violations can have large effects on esti-
mates of our parameter. To test for this potential issue, we considered different
truncation bounds for our treatment probabilities. Specifically, we considered using
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Figure 4: Cross-valided risk estimates (using non-negative log-likelihood loss) and
95% confidence interval for the treatment and censoring mechanisms. A number
of candidates had cross-validated risks too high to plot in the specified window and
consequently are not shown. Mean: marginal probability, Time: logistic regres-
sion with time variable only, GLM: logistic regression with all confounders, AIC
step: stepwise regression using the Akaike information criterion, GAM: generalized
additive model, KNN: k-nearest neighbors, LASSO: least absolute shrinkage and
selection operator, MARS: multivariate adaptive regression splines, GBM: general-
ized boosted regression models, SVM: support vector machines, Parametric: user
specified logistic models using a subset of the confounders.
a bound of 0.001 and using untruncated probabilities. No differences were seen in
the resulting mean outcome estimates.
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Figure 5: Survival curves adjusting for potential confounders.
Table 5: Time-specific average treatment effects adjusted for measured potential
confounders. (a) compares the intervention immediate LREC availability without
enrollment to never having LREC available; (b) compares the intervention imme-
diate LREC availability and enrollment to immediate LREC availability without
enrollment.
(a) EYa¯=10(t∗)−EYa¯=00(t∗) (b) EYa¯=11(t∗)−EYa¯=10(t∗)
Time (t∗) Estimate (95% CI) p-value Estimate (95% CI) p-value
1 0.00 (0.00,0.00) 0.81 0.00 (0.00,0.01) 0.58
2 0.02 (0.02,0.03) 0.00 -0.03 (-0.05,-0.02) 0.00
3 0.04 (0.03,0.05) 0.00 -0.05 (-0.07,-0.03) 0.00
4 0.04 (0.03,0.06) 0.00 -0.07 (-0.08,-0.05) 0.00
8 Discussion
We have presented a comprehensive approach to applying longitudinal targeted
minimum loss-based estimation to evaluate the impact of the LREC program. Cor-
responding code for the analyses have been uploaded to an online public reposi-
tory as an R-package at www.github.com/tranlm/lrecImpact. The results support a
somewhat negligible impact of implementation and enrollment, with the lowest sur-
vival among patients with immediate LREC availability never enrolling and similar
survival among the other two interventions (Figure 5). Subjects enrolling immedi-
ately into the LREC program have almost identical survival to subjects never being
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exposed to the program. While the magnitude of difference in survival increased
with time, this difference is modest.
It is important to note that our target population is comprised only of sub-
jects at low risk of mortality. Consequently, the majority of our results are driven
primarily by subjects not remaining in care, as the number of deaths expected to be
observed will be low. In our study, only 104 of the total 1,206 failure events were
from deaths. A sensitivity analysis using only loss to follow-up as the outcome
resulted in similar estimates.
We chose 90-day intervals for our time points in the current study, due to the
understanding that patients would have visits approximately every 3-months. While
smaller intervals could have been chosen, doing so can reduce the probability of fol-
lowing a given regime of interest given observed covariates (i.e. increase the extent
of practical positivity violations), both by decreasing the probability of availability
and enrollment occurring in the first interval, and because the probability of never
enrolling given observed covariates involves taking a cumulative probability of not
enrolling given the observed past over many more time points. Furthermore, the
use of smaller intervals results in more time points, leading to higher computational
costs. On the other hand, the use of larger intervals leads to discarding information
in order to preserve time ordering, which can result in a less complete control for
confounding as well as failure to capture the full causal effect of the intervention.
In order to preserve time ordering, only covariate and outcome values measured at
the end of the prior interval are considered possible causes of enrollment and avail-
ability in an interval. Longer intervals result in more problems with the assumption.
We tested whether there was an effect in our study by re-running the analyses using
30-day intervals. The resulting survival estimates were similar to the ones reported
here.
As with all studies, there are limitations that need to be considered. Firstly,
it is possible that we did not sufficiently adjust for all the potential confounders.
For example, the majority of subjects who had immediate availability and never
enrolled had initial eligibility occur after the LREC program had already started.
These subjects experiencing incidental eligibility (as opposed to prevalent eligibil-
ity from those eligible prior to the LREC program initiation) may have had factors
placing them at higher risk. In addition, in defining our composite outcome ”dead
or lost to follow up” we implicitly assumed that not being seen in clinic for 6.5
months is an undesirable outcome reflecting out of care status. In practice, some of
these patients might represent unreported transfers to care in an alternative clinic. If
true, however, this would have to occur disproportionately among treatment groups
in order to affect the average treatment effect estimates presented here. Lastly, our
analysis considered subjects from the same clinics to be causally independent of
each other. In specifying our causal model we made a key decision to use an in-
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dividual level NPSEM despite our interest in both an individual and a clinic level
exposure variable. Such a formulation assumes that individuals within a given clinic
are causally independent, and in particular, that the exposure received by one patient
does not impact the outcome of another (the assumption of no causal interference)
(Kline, 2011, Tchetgen and VanderWeele, 2012). A different formulation is possi-
ble that uses a hierarchical or clinic level NPSEM and corresponding hierarchical
identification and analysis. We can think of the corresponding experiment as ran-
domizing entire clinics to start the LREC program and within clinics with LREC
available, randomizing patients to enroll. However, the sample size then becomes
driven by the number of clinics and identification would require adequate variabil-
ity in the introduction of LREC across clinics (Tchetgen and VanderWeele, 2012).
We therefore pursued an individual level formulation, while noting the limitations
of this approach. Future research into improved approaches to interference effects
in this setting should be undertaken.
We end by stating that, while not conducted here, this framework can be
easily generalized to include dynamic interventions that are dependent upon other
covariates. For example, there could be interest in intervening to enforce enrollment
only on patients who retain eligibility during follow-up while exempting patients
who do not. Another option to consider is the use of marginal structural models to
smooth treatment effects across time points, as well as availability and enrollment
times (Robins et al., 1999, 2000a, Robins, 2000a, Petersen et al., 2013) though care
should be taken when implementing as the number of regimes with available data
would be limited. These models allow us to project the true underlying dose re-
sponse curve onto a working parametric model, allowing us to conduct inference
on a smaller set of parameters. The ltmle package includes a TMLE for causal pa-
rameters defined as the projection of the survival or failure curve onto user-specified
parametric models.
In summary we applied the targeted learning roadmap to longitudinal data
with a multilevel longitudinal treatment of interest to analyze a nurse-based triage
system among HIV patients in East Africa. This included both definition and iden-
tification of our causal parameter. Issues with positivity were handled with careful
selection of our target causal parameter. Nuisance parameters were estimated us-
ing Super Learner, a cross-validation ensemble algorithm using both parametric
and machine learning algorithms. Observations for the estimation of the treatment
mechanisms were pooled across time points, which aided us in estimating the cen-
soring mechanism due to clinical transfers. Various approaches were implemented
aimed at ensuring the machine learning estimates of the ICEs would respect the
underlying statistical model. Estimates of survival at each time point were then
contrasted by their differences and inference derived using the empirical influence
functions. The results show a somewhat negligible impact of both availability and
http://biostats.bepress.com/ucbbiostat/paper345
enrollment in the LREC program on in-care survival.
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Appendix
Proof that O and Or have equivalent influence functions.
We provide a proof here showing that the influence function for the full data O
is equivalent to the influence function we solve for in our analysis based on the
reduced data Or = O/L1(K+1).
Firstly, we know the efficient influence function D(P) for the reduced data
Or. Our goal is to compute the efficient influence function for the full data O for
this same parameter (but now as a function on a model on O instead of Or).
Recall that one can compute an efficient influence function D∗(P) by first
deriving an influence function of any estimator, and then projecting this influence
function on the tangent space T (P) of the model. D(P) is one such influence func-
tion since it is the influence function of the TMLE ignoring L1(K + 1). Thus, the
desired efficient influence function is D∗(P) = pi(D(P)|T (P)) where pi is the pro-
jection operator acting onto T (P).
Now, we note that the likelihood of O can be factorized as P(L1(K+1)|Y (K+
1))P(Or). Thus, the tangent space is the orthogonal sum of the tangent space T1(P)
of the first factor P(L1(K + 1)|Y (K + 1)) and the tangent space Tr(P) of P(Or).
Consequently, pi(D(P)|T (P)) = pi(D(P)|T1(P)) + pi(D(P)|Tr(P)). However, the
target parameter is only a function of P(Or), such that P(L1(K + 1)|Y (K + 1))
is actually a nuisance parameter. Because the efficient influence function is al-
ways orthogonal to a nuisance tangent space (i.e. the space of scores one gets
by varying the nuisance parameters), it is also orthogonal to the tangent space of
P(L1(K+1)|Y (K+1)). It follows that D∗(P) = pi(D(P)|Tr(P)) (i.e. the component
in T1(P) is zero).
However, D(P) is the efficient influence function of the target parameter
based on Or and is therefore an element of the tangent space of P(Or), so that D(P)
is in Tr(P). This results in pi(D(P)|Tr(P)) = D(P), which completes the proof that
D∗(P) = D(P). That is, the efficient influence function of our parameter based on
Or is the same as the efficient influence function of our parameter based on O.
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